Disparities in pediatric preventive care in the United States, 1993-2002

Simon J Hambidge1, Caroline Bublitz Emsermann, Steven Federico

  • 1Denver Health Medical Center, Denver Community Health Services, 777 Bannock Street, Denver, CO 80204, USA. simon.hambidge@uchsc.edu

Insights

Black and Latino children receive less preventive counseling during well-child visits compared to white children. These disparities persist even after accounting for other medical factors.

Area of Science:

  • Pediatrics
  • Public Health
  • Health Disparities

Background:

  • Well-child visits (WCVs) are crucial for preventive care and health screening in children.
  • Racial and ethnic disparities in healthcare delivery are a significant public health concern.

Purpose of the Study:

  • To quantify physician-reported preventive counseling and screening during WCVs.
  • To examine racial and ethnic disparities in these preventive services.

Main Methods:

  • Cross-sectional study utilizing data from the National Ambulatory Medical Care Survey (1993-2002).
  • Analysis included children aged 0-18 years attending WCVs in office-based physician practices.
  • Main outcome measures were preventive counseling and screening activities.

Main Results:

  • White children received more preventive counseling than black or Latino children during WCVs (72% vs. 61% vs. 61%).
  • No significant differences were observed in screening for conditions like elevated blood pressure, anemia, vision/hearing acuity, or lead toxicity.
  • Adjusted analyses revealed black and Latino children were less likely to receive counseling, and black children less likely to receive screening services.

Conclusions:

  • Physician reports indicate that black and Latino children receive less counseling during WCVs compared to white children.
  • These disparities in preventive counseling were not explained by the presence of secondary diagnoses or prescribed medications.
  • The findings highlight significant racial and ethnic disparities in preventive care delivery during pediatric visits.
Abstract

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...